All Stories

  1. More early bleeds associated with high baseline direct oral anticoagulant levels in atrial fibrillation: the MAS study

    Article • Blood Advances, September 2024, American Society of Hematology

    Michela Cini

  2. Thrombotic events associated with low baseline direct oral anticoagulant levels in atrial fibrillation: the MAS study

    Article • Blood Advances, April 2024, American Society of Hematology

    Michela Cini

  3. Incidence and clinical outcomes of heparin-induced thrombocytopenia: 11 year experience in a tertiary care university hospital

    Article • Internal and Emergency Medicine, August 2023, Springer Science + Business Media

    Michela Cini

  4. Venous Thromboembolism in Women of Childbearing Age: Insights from the START Registry

    Article • Thrombosis and Haemostasis, June 2023, Thieme Publishing Group

    Michela Cini

  5. Recurrences and bleeding during extended treatment of patients with venous thromboembolism: results of the international, prospective, observational WHITE study

    Article • International Angiology, March 2023, Edizioni Minerva Medica

    Michela Cini

  6. Evaluation of Coaguchek<sup>®</sup>Pro II coagulation testing device performance to assess direct oral anticoagulant action. The DOAC-CHECK study

    Article • Bleeding Thrombosis and Vascular Biology, December 2022, PAGEPress Publications

    Michela Cini

  7. Thrombotic burden, D-dimer levels and complete compression ultrasound for diagnosis of acute symptomatic deep vein thrombosis of the lower limbs

    Article • Thrombosis Research, May 2022, Elsevier

    Michela Cini

  8. Influence of clinical presentation, site, and extent of venous thrombosis on decision about duration of anticoagulation: Data from the international, prospective, observational WHITE study

    Article • Thrombosis Research, March 2022, Elsevier

    Michela Cini

  9. Unprovoked or provoked venous thromboembolism: not the prevalent criterion to decide on anticoagulation extension in clinical practice of various countries—the prospective, international, observational WHITE study

    Article • Internal and Emergency Medicine, July 2021, Springer Science + Business Media

    Michela Cini

  10. Anticoagulation Duration After First Venous Thromboembolism: Real-Life Data From the International, Observational WHITE Study

    Article • Clinical and Applied Thrombosis/Hemostasis, January 2021, SAGE Publications

    Michela Cini

  11. DOAC plasma levels measured by chromogenic anti‐Xa assays and HPLC‐UV in apixaban‐ and rivaroxaban‐treated patients from the START‐Register

    Article • International Journal of Laboratory Hematology, February 2020, Wiley

    Michela Cini

  12. An in vitro study to investigate the interference of enoxaparin on plasma levels of direct oral factor Xa inhibitors measured by chromogenic assays

    Article • International Journal of Laboratory Hematology, January 2019, Wiley

    Michela Cini

  13. Comparison of five specific assays for determination of dabigatran plasma concentrations in patients enrolled in the START-Laboratory Register

    Article • International Journal of Laboratory Hematology, January 2018, Wiley

    Michela Cini, Dr GUALTIERO PALARETI

  14. Endothelial activation in patients with superficial vein thrombosis (SVT) of the lower limbs

    Article • Thrombosis Research, September 2017, Elsevier

    Michela Cini

  15. Thrombin generation and intracranial atherosclerotic disease in patients with a transient ischaemic attack

    Article • Thrombosis Research, July 2017, Elsevier

    Michela Cini

  16. Variability of cut-off values for the detection of lupus anticoagulants: results of an international multicenter multiplatform study

    Article • Journal of Thrombosis and Haemostasis, April 2017, Wiley

    Michela Cini

  17. Poor comparability of coagulation screening test with specific measurement in patients receiving direct oral anticoagulants: results from a multicenter/multiplatform study

    Article • Journal of Thrombosis and Haemostasis, October 2016, Wiley

    Michela Cini

  18. Diagnostic Accuracy of a New d-Dimer Assay (Sclavo Auto d-Dimer) for Exclusion of Deep Vein Thrombosis in Symptomatic Outpatients

    Article • Clinical and Applied Thrombosis/Hemostasis, July 2016, SAGE Publications

    Michela Cini

  19. Measurement of factor XIII (FXIII) activity by an automatic ammonia release assay using iodoacetamide blank-procedure: no more overestimation in the low activity range and better detection of severe FXIII deficiencies

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), January 2016, De Gruyter

    Michela Cini

  20. Evaluation of a chemiluminescent immunoassay, the HemosIL AcuStar D-Dimer, in outpatients with clinically suspected deep venous thrombosis

    Article • International Journal of Laboratory Hematology, September 2015, Wiley

    Michela Cini

  21. D-dimer for the diagnosis of upper extremity deep and superficial venous thrombosis

    Article • Thrombosis Research, April 2015, Elsevier

    Michela Cini

  22. Rivaroxaban in the Treatment of Heparin-Induced Thrombocytopenia

    Article • Journal of Thrombosis and Thrombolysis, March 2015, Springer Science + Business Media

    Michela Cini

  23. D-dimer, FVIII and thrombotic burden in the acute phase of deep vein thrombosis in relation to the risk of post-thrombotic syndrome

    Article • Thrombosis Research, August 2014, Elsevier

    Michela Cini

  24. Inherited and acquired thrombophilic alterations in patients with superficial vein thrombosis of lower limbs

    Article • Thrombosis and Haemostasis, February 2014, Schattauer GmbH

    Michela Cini

  25. D-dimer use for deep venous thrombosis exclusion in elderly patients: a comparative analysis of three different approaches to establish cut-off values for an assay with results expressed in D-dimer units

    Article • International Journal of Laboratory Hematology, January 2014, Wiley

    Michela Cini

  26. Influence of proband's characteristics on the risk for venous thromboembolism in relatives with factor V Leiden or prothrombin G20210A polymorphisms

    Article • Blood, August 2013, American Society of Hematology

    Michela Cini

  27. The Wells rule and D-dimer for the diagnosis of isolated distal deep vein thrombosis

    Article • Journal of Thrombosis and Haemostasis, October 2012, Wiley

    Michela Cini

  28. The influence of VKORC1 3730 G > A polymorphism on warfarin dose: reply

    Article • European Journal of Clinical Pharmacology, October 2012, Springer Science + Business Media

    Michela Cini

  29. The F11 rs2289252 polymorphism is associated with FXI activity levels and APTT ratio in women with thrombosis

    Article • Thrombosis Research, September 2012, Elsevier

    Michela Cini

  30. A new warfarin dosing algorithm including VKORC1 3730 G > A polymorphism: comparison with results obtained by other published algorithms

    Article • European Journal of Clinical Pharmacology, February 2012, Springer Science + Business Media

    Michela Cini

  31. Age and gender specific cut-off values to improve the performance of d-dimer assays to predict the risk of venous thromboembolism recurrence

    Article • Internal and Emergency Medicine, May 2011, Springer Science + Business Media

    Michela Cini

  32. D-dimer and residual vein obstruction as risk factors for recurrence during and after anticoagulation withdrawal in patients with a first episode of provoked deep-vein thrombosis

    Article • Thrombosis and Haemostasis, February 2011, Schattauer GmbH

    Michela Cini

  33. No early signs of atherosclerotic alterations in carriers of inherited thrombophilia

    Article • European Journal of Internal Medicine, August 2010, Elsevier

    Michela Cini

  34. Evaluation of a new automated panel of assays for the detection of anti-PF4/heparin antibodies in patients suspected of having heparin-induced thrombocytopenia

    Article • Thrombosis and Haemostasis, June 2010, Schattauer GmbH

    Michela Cini

  35. Thalidomide-dexamethasone as up-front therapy for patients with newly diagnosed multiple myeloma: thrombophilic alterations, thrombotic complications, and thromboprophylaxis with low-dose warfarin

    Article • European Journal Of Haematology, May 2010, Wiley

    Dr ALESSANDRO Gozzetti, Michela Cini

  36. Multicenter evaluation of a new quantitative highly sensitive D-dimer assay, the Hemosil® D-dimer HS 500, in patients with clinically suspected venous thromboembolism

    Article • Thrombosis Research, May 2010, Elsevier

    Michela Cini

  37. Thrombophilic risk factors and peripheral arterial disease severity

    Article • Thrombosis and Haemostasis, April 2010, Schattauer GmbH

    Michela Cini

  38. Pharmacodynamics of low molecular weight heparin in patients undergoing bariatric surgery: A prospective, randomised study comparing two doses of parnaparin (BAFLUX STUDY)

    Article • Thrombosis Research, December 2009, Elsevier

    Michela Cini

  39. G20210A Prothrombin Mutation and Critical Limb Ischaemia in Patients with Peripheral Arterial Disease

    Article • European Journal of Vascular and Endovascular Surgery, July 2009, Elsevier

    Michela Cini

  40. Different cut-off values of quantitative D-dimer methods to predict the risk of venous thromboembolism recurrence: a post-hoc analysis of the PROLONG study

    Article • Haematologica, June 2008, Ferrata Storti Foundation (Haematologica)

    Michela Cini

  41. Influence of low-density lipoprotein (LDL) receptor-related protein and ABO blood group genotypes on factor XI levels

    Article • Thrombosis and Haemostasis, March 2008, Schattauer GmbH

    Michela Cini

  42. D-dimer and factor VIII are independent risk factors for recurrence after anticoagulation withdrawal for a first idiopathic deep vein thrombosis

    Article • Thrombosis Research, January 2008, Elsevier

    Michela Cini

  43. Abnormally short activated partial thromboplastin time values are associated with increased risk of recurrence of venous thromboembolism after oral anticoagulation withdrawal

    Article • British Journal of Haematology, July 2006, Wiley

    Michela Cini

  44. D-dimer levels in combination with residual venous obstruction and the risk of recurrence after anticoagulation withdrawal for a first idiopathic deep vein thrombosis

    Article • Thrombosis and Haemostasis, September 2005, Schattauer GmbH

    Michela Cini

  45. Poor anticoagulation quality in the first 3 months after unprovoked venous thromboembolism is a risk factor for long-term recurrence

    Article • Journal of Thrombosis and Haemostasis, May 2005, Wiley

    Michela Cini

  46. High plasma levels of factor VIII and risk of recurrence of venous thromboembolism

    Article • British Journal of Haematology, January 2004, Wiley

    Michela Cini

  47. A new rapid bedside assay for d-dimer measurement (Simplify d-dimer) in the diagnostic work-up for deep vein thrombosis

    Article • Journal of Thrombosis and Haemostasis, December 2003, Wiley

    Michela Cini

  48. Additive thrombin inhibition by fast moving heparin and dermatan sulfate explains the anticoagulant effect of sulodexide, a natural mixture of glycosaminoglycans

    Article • Thrombosis Research, March 2003, Elsevier

    Michela Cini

  49. A new rapid bedside assay for quantitative testing of D-Dimer (Cardiac D-Dimer) in the diagnostic work-up for deep vein thrombosis

    Article • Thrombosis Research, January 2003, Elsevier

    Michela Cini

  50. Deep-vein thrombosis in patients with multiple myeloma receiving first-line thalidomide-dexamethasone therapy

    Article • Blood, August 2002, American Society of Hematology

    Michela Cini